SAR and lead optimization of an HIV-1 Vif-APOBEC3G axis inhibitor

Idrees Mohammed, Maloy K. Parai, Xinpeng Jiang, Natalia Sharova, Gatikrushna Singh, Mario Stevenson, Tariq M. Rana

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

We describe structure-activity relationship and optimization studies of RN-18, an HIV-1 Vif-APOBEC3G axis inhibitor. Targeted modifications of RN-18 ring C, ring B, ring A, bridge A-B, and bridge B-C were performed to identify the crucial structural features, which generated new inhibitors with similar (4g and 4i) and improved (5, 8b, and 11) activities. Two potent water-soluble RN-18 analogues, 17 and 19, are also disclosed, and we describe the results of pharmacological studies with compound 19. The findings described here will be useful in the development of more potent Vif inhibitors and in the design of probes to identify the target protein of RN-18 and its analogues.

Original languageEnglish
Pages (from-to)465-469
Number of pages5
JournalACS Medicinal Chemistry Letters
Volume3
Issue number6
DOIs
StatePublished - May 14 2012

Fingerprint

Structure-Activity Relationship
HIV-1
Pharmacology
Water
Proteins

Keywords

  • HIV-1 Vif-APOBEC3G axis inhibition
  • pharmacological studies
  • RN-18
  • structure-activity relationship and optimization

ASJC Scopus subject areas

  • Organic Chemistry
  • Drug Discovery
  • Biochemistry

Cite this

Mohammed, I., Parai, M. K., Jiang, X., Sharova, N., Singh, G., Stevenson, M., & Rana, T. M. (2012). SAR and lead optimization of an HIV-1 Vif-APOBEC3G axis inhibitor. ACS Medicinal Chemistry Letters, 3(6), 465-469. https://doi.org/10.1021/ml300037k

SAR and lead optimization of an HIV-1 Vif-APOBEC3G axis inhibitor. / Mohammed, Idrees; Parai, Maloy K.; Jiang, Xinpeng; Sharova, Natalia; Singh, Gatikrushna; Stevenson, Mario; Rana, Tariq M.

In: ACS Medicinal Chemistry Letters, Vol. 3, No. 6, 14.05.2012, p. 465-469.

Research output: Contribution to journalArticle

Mohammed, I, Parai, MK, Jiang, X, Sharova, N, Singh, G, Stevenson, M & Rana, TM 2012, 'SAR and lead optimization of an HIV-1 Vif-APOBEC3G axis inhibitor', ACS Medicinal Chemistry Letters, vol. 3, no. 6, pp. 465-469. https://doi.org/10.1021/ml300037k
Mohammed, Idrees ; Parai, Maloy K. ; Jiang, Xinpeng ; Sharova, Natalia ; Singh, Gatikrushna ; Stevenson, Mario ; Rana, Tariq M. / SAR and lead optimization of an HIV-1 Vif-APOBEC3G axis inhibitor. In: ACS Medicinal Chemistry Letters. 2012 ; Vol. 3, No. 6. pp. 465-469.
@article{23693aadd8f541938b493ad36a354eae,
title = "SAR and lead optimization of an HIV-1 Vif-APOBEC3G axis inhibitor",
abstract = "We describe structure-activity relationship and optimization studies of RN-18, an HIV-1 Vif-APOBEC3G axis inhibitor. Targeted modifications of RN-18 ring C, ring B, ring A, bridge A-B, and bridge B-C were performed to identify the crucial structural features, which generated new inhibitors with similar (4g and 4i) and improved (5, 8b, and 11) activities. Two potent water-soluble RN-18 analogues, 17 and 19, are also disclosed, and we describe the results of pharmacological studies with compound 19. The findings described here will be useful in the development of more potent Vif inhibitors and in the design of probes to identify the target protein of RN-18 and its analogues.",
keywords = "HIV-1 Vif-APOBEC3G axis inhibition, pharmacological studies, RN-18, structure-activity relationship and optimization",
author = "Idrees Mohammed and Parai, {Maloy K.} and Xinpeng Jiang and Natalia Sharova and Gatikrushna Singh and Mario Stevenson and Rana, {Tariq M.}",
year = "2012",
month = "5",
day = "14",
doi = "10.1021/ml300037k",
language = "English",
volume = "3",
pages = "465--469",
journal = "ACS Medicinal Chemistry Letters",
issn = "1948-5875",
publisher = "American Chemical Society",
number = "6",

}

TY - JOUR

T1 - SAR and lead optimization of an HIV-1 Vif-APOBEC3G axis inhibitor

AU - Mohammed, Idrees

AU - Parai, Maloy K.

AU - Jiang, Xinpeng

AU - Sharova, Natalia

AU - Singh, Gatikrushna

AU - Stevenson, Mario

AU - Rana, Tariq M.

PY - 2012/5/14

Y1 - 2012/5/14

N2 - We describe structure-activity relationship and optimization studies of RN-18, an HIV-1 Vif-APOBEC3G axis inhibitor. Targeted modifications of RN-18 ring C, ring B, ring A, bridge A-B, and bridge B-C were performed to identify the crucial structural features, which generated new inhibitors with similar (4g and 4i) and improved (5, 8b, and 11) activities. Two potent water-soluble RN-18 analogues, 17 and 19, are also disclosed, and we describe the results of pharmacological studies with compound 19. The findings described here will be useful in the development of more potent Vif inhibitors and in the design of probes to identify the target protein of RN-18 and its analogues.

AB - We describe structure-activity relationship and optimization studies of RN-18, an HIV-1 Vif-APOBEC3G axis inhibitor. Targeted modifications of RN-18 ring C, ring B, ring A, bridge A-B, and bridge B-C were performed to identify the crucial structural features, which generated new inhibitors with similar (4g and 4i) and improved (5, 8b, and 11) activities. Two potent water-soluble RN-18 analogues, 17 and 19, are also disclosed, and we describe the results of pharmacological studies with compound 19. The findings described here will be useful in the development of more potent Vif inhibitors and in the design of probes to identify the target protein of RN-18 and its analogues.

KW - HIV-1 Vif-APOBEC3G axis inhibition

KW - pharmacological studies

KW - RN-18

KW - structure-activity relationship and optimization

UR - http://www.scopus.com/inward/record.url?scp=84862280748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862280748&partnerID=8YFLogxK

U2 - 10.1021/ml300037k

DO - 10.1021/ml300037k

M3 - Article

AN - SCOPUS:84862280748

VL - 3

SP - 465

EP - 469

JO - ACS Medicinal Chemistry Letters

JF - ACS Medicinal Chemistry Letters

SN - 1948-5875

IS - 6

ER -